Follow this request
There are 2 people following this request
Act on what you've learnt
Similar requests
H1N1 Influenza Vaccine
To Scottish Government by Mr McGillivray 19 August 2009
H1N1 Vaccination
To Scottish Government by Mr McGillivray 29 October 2009
H1N1 Influenza Vaccine
To Department of Health by Mr McGillivray 19 August 2009
H1N1 Vaccination
To Department of Health by Mr McGillivray 29 October 2009
Seasonal Influenza Deaths
To Scottish Government by Mr McGillivray 2 November 2009
What is the goal of the Vaccine Commission
To Department of Health by lee edwardes 2 September 2011
Innoculation
To Cornwall and Isles of Scilly Primary Care Trust (PCT) by Roger Whitwam 5 February 2010
Ukranian Swine Flu
To Medical Research Council by Ken 16 December 2009
Pharmacovigilance strategy for pandemic vaccines and antivirals
To Medicines and Healthcare products Regulatory Agency by Martin Green 12 December 2009
SLA for Enhanced Services
To Walsall Teaching Primary Care Trust (PCT) by Emma Griffiths 7 December 2011
H1N1 Vaccine Immunity from Prosecution
Mr McGillivray made this Freedom of Information request to Scottish Government
The request was partially successful.
From: Mr McGillivray
1 September 2009
Dear Sir or Madam,
Please can you clarify:
1. Whether the immunity from liability for any adverse vaccine
effects granted to manufacturers of the H1N1 influenza vaccine by
the UK Government applies to vaccination in Scotland.
2. If it does not apply in Scotland can you state whether or not
the Scottish Government has granted or intends to grant vaccine
manufacturers similar immunity from liability.
3. Whether such immunity could be granted directly by the Scottish
Government under existing legislation (please specify which act/s)
or if it would require the consent of the Scottish Parliament.
Yours faithfully,
Mr McGillivray
Scottish Government
11 September 2009
Chief Medical Officer and Public Health Directorate abcdefghijklmnopqrstu
Public Health Division
T: 0131-244 5662 F: 0131-244 2606
E: [email address]
Mr McGillivray
By email to: abcd
[1][FOI #17582 email]
___
Our ref: FoI/09/01147
11 September 2009
Dear Mr McGillivray
Thank you for your further email request dated 1 September for information
under the Freedom of Information (Scotland) Act 2002 about the plans to
vaccinate against influenza A (H1N1). We have now completed our search
for the information you requested and I have been asked to provide a
response to the questions you have raised.
The UK Government, on behalf of the four administrations, signed advance
purchase agreements in June 2007 and accepted liability for the safety of
any vaccines that would be produced as a contingency. All governments
signing up to an advance purchase agreement were expected to provide an
indemnity for the vaccine and neither manufacturer would sign the
contracts without it. The Government's decision was based on the best
procurement and legal advice. Accepting liability in this way is in line
with Government accounting rules and was cleared by the Public Accounts
Committee at the time.
The A (H1N1) vaccines that will be used in Scotland and the UK will be
subject to the licensing and regulation requirements for any new
vaccines. We will only use influenza A (H1N1) vaccines if we have
confidence in their safety.
If you are unhappy with this response to your request, you may ask us to
carry out an internal review, by writing to Dr Kevin Woods, Director
General - Health, Floor 1E.07 - St Andrews House, Regent Road, Edinburgh,
EH1 3DG. Your request should explain why you wish a review to be carried
out, and should be made within 40 working days of receipt of this letter,
and we will reply within 20 working days of receipt. If you are not
satisfied with the result of the review, you then have the right to make a
formal complaint to the Scottish Information Commissioner.
Yours sincerely
Syed Kerbalai
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
References
Visible links
1. mailto:[FOI #17582 email]
From: Mr McGillivray
14 September 2009
Dear Sir or Madam,
Please can you comment on the annotation to this request left by
Keith Weir on 12th September 2009 quoting an article in the Sunday
Post regarding the vaccination.
Please can you state what measures the government will take to
allay any public concerns that may be raised by the poll that
suggests half of doctors and a third of nurses will decline to
receive the vaccine.
In light of the polls suggesting half of doctors and a third of
nurses will refuse the vaccine, what does the government anticipate
will be the percentage of vaccine uptake in the population as a
whole and will it adjust its vaccine purchase requirements
accordingly to reduce costs?
What measures has the government taken to counter "scaremongering"
over the vaccine by certain individuals including journalist Jane
Burgermeister who has set up a website www.theflucase.com
Is the Scottish Government aware of the Criminal Charges filed in
Austria and the USA against the vaccine manufacturers by Jane
Burgermeister. If so what measures if any have been taken to
satisfy the government that these charges are vexatious.
Is the Scottish Government aware of claims in the media that the UK
Government has asked senior neurologists to be alert for an
increase in cases of the neurological condition Guillain Barre
Syndrome (GBS) once the vaccination programme begins?
Yours faithfully,
Mr McGillivray
Scottish Government
9 October 2009
Chief Medical Officer and Public Health Directorate abcdefghijklmnopqrstu
Public Health Division
T: 0131-244 2330 F: 0131-244 2606
E: [email address]
Mr McGillivray
By email to: abcd
[1][FOI #17582 email]
___
Our ref: FoI/09/01254
12 October 2009
Dear Mr McGillivray
Thank you for your further questions dated 14 September for information
under the Freedom of Information (Scotland) Act 2002 (FOISA) about the
plans to vaccinate against influenza A (H1N1). We have now completed our
search for the information you requested and detail this below.
1. Please can you state what measures the
Government will take to allay any public
concerns that may be raised by the poll that
suggests half of doctors and a third of
nurses will decline to receive the vaccine.
The Scottish Government is working closely with other UK administrations
to develop a coherent UK-wide advertising campaign to ensure the public
and professionals can make an informed personal choice about the influenza
A (H1N1) vaccines based on accurate information. Whilst the Scottish
Government strongly advises healthcare professionals in the vaccination
priority groups (including GPs and Nurses) to receive the vaccine, we are
aware that not everyone will wish to do so. Vaccination is not mandatory
for anyone, including healthcare professionals.
2. In light of the polls suggesting half of doctors and a third of nurses
will refuse the
vaccine, what does the Government anticipate will be the percentage of
vaccine uptake in the population as a whole and will it adjust its vaccine
purchase requirements accordingly to reduce costs?
While we would hope that a high number of people will receive the
vaccination in order to protect themselves from the H1N1 virus, the
Scottish Government has not anticipated a specific level of uptake rate.
However experience from the annual seasonal flu vaccination programme,
which currently sees a 75% uptake rate in people aged over 65 years and
almost 50% in those under the age of 65 receiving the seasonal flu
vaccine, indicates that at risk are willing to attend for vaccination and
recognise the benefits and protection that being vaccinated provides.
In relation to vaccine contracts currently in place with vaccine
manufacturers are on a UK wide basis and Scotland cannot act on its own to
alter these purchase arrangements. There does however already exist a
break point in the contract whereby the UK and administrations can
consider the need for further vaccines in early 2010 based on the severity
and spread of the virus.
3. What measures has the Government taken to
counter "scaremongering" over the
vaccine by certain individuals including journalist
Jane Burgermeister who has set up
a website [2]www.theflucase.com.
4. Is the Scottish Government aware of the criminal
charges filed in Austria and the
USA against the vaccine manufacturers by Jane
Burgermeister. If so what measures
if any have been taken to satisfy the Government
that these charges are vexatious.
I am unable to comment on issues published by a third party particularly
if the content of such an article relates to legal charges that have been
filed. The UK-wide advertising campaign will provide accurate information
to inform the public about the risks and benefits of vaccination to allow
them to make informed decisions.
5. Is the Scottish Government aware of claims in
the media that the UK Government
has asked senior neurologists to be alert for an
increase in cases of the neurological
condition Guillain Barre Syndrome (GBS) once the
vaccination programme begins.
I am unable to comment on claims made in the media however can advise that
the European Medicines Agency (EMEA) have requested that manufacturers
implement plans to actively investigate and monitor the safety of vaccines
as soon as they are used across the EU so that action can be taken as
early as possible if a safety issue emerges. The Medicines Healthcare
Regulatory Authority, which is the agency responsible for the safety of
medicines in the UK, has developed detailed real-time surveillance for
serious adverse reactions such as Guillian-Barré Syndrome based on their
experience in previous vaccination programmes.
If you are unhappy with this response to your request, you may ask us to
carry out an internal review, by writing to Dr Kevin Woods, Director
General - Health, Floor 1E.07 - St Andrews House, Regent Road, Edinburgh,
EH1 3DG. Your request should explain why you wish a review to be carried
out, and should be made within 40 working days of receipt of this letter,
and we will reply within 20 working days of receipt. If you are not
satisfied with the result of the review, you then have the right to make a
formal complaint to the Scottish Information Commissioner.
Yours sincerely
Mike Palmer
Deputy Director
Public Health Division
show quoted sections
Communications via the GSi may be automatically logged, monitored and/or
recorded for legal purposes.
References
Visible links
1. mailto:[FOI #17582 email]
2. http://www.theflucase.com/
Kevin left an annotation ( 3 April 2011)
People are waking up........ the house of cards is falling....... the new world order is failing....... TRUE FREEDOM is awakening, not the freedom they call "democracy" keep up the fight against the system. Oh by the way, do you want to buy this tablet I just invented ? It cures all cancer and HIV and it extends your life by fifty years, it also might make you autistic and make you infertile, but if you get those things from it, its not my fault !!!
Things to do with this request
- Add an annotation (to help the requester or others)
- Download a zip file of all correspondence
Make and explore Freedom of Information requests






Keith Weir left an annotation (12 September 2009)
Immunity granted to controversial flu jab
By Iain Harrison
TAXPAYERS could face a multi-million-pound compensation bill if patients suffer side effects from the swine flu vaccine.
The Sunday Post has learned that the UK government has granted legal immunity to the makers of the controversial jab.
That means the State will be liable for any claims for damages that might result from the planned mass vaccination programme.
The news comes a week after a poll revealed that up to half of family doctors are refusing to be vaccinated against swine flu.
Almost three in four claimed this was because of safety concerns. A third of nurses are taking a similar stance.
The jab is currently being fast-tracked through normal development stages and will not be fully tested before being administered to patients.
Fears
Last night a patients’ watchdog voiced fears that those receiving the drug first because they are in a priority group will be “guinea pigs” for the pharmaceutical companies.
Margaret Watt, chair of the Scotland Patients’ Association, said, “It’s morally wrong to give the vaccine makers legal immunity.
“If these vaccines haven’t been fully tested and the vaccination programme backfires then the public should not have to foot the bill.
“It worries me that the manufacturers are refusing to accept liability. The health authorities must make this abundantly clear to people who take the vaccine.”
The decision by the UK Government to grant swine flu jab makers legal immunity mirrors a settlement struck by the US authorities in June.
The last time a mass swine flu inoculation programme was conducted there it caused more deaths than the disease it was designed to combat.
That campaign, in 1976, was halted after thousands filed compensation claims contending they’d suffered side-effects from the shots.
Unsurprising
Cameron Fyfe, a litigation specialist at Ross Harper solicitors in Glasgow, said it was unsurprising pharmaceutical firms had taken steps to avoid a repeat scenario.
But he added, “I haven’t come across this type of arrangement before but I can understand it given they’ve had their fingers burnt in the past.
“To succeed with an action a litigant would have to show that the vaccine manufacturers did have enough time to develop a jab that was safe.
“The pharmaceutical firm would then claim its losses back from the Government.”
Health officials in Scotland say they hope to begin vaccinating priority groups, including pregnant women and front line medical staff, from mid-October.
Early indications suggest the jab will be available by then, although doubts about its safety remain due to the limited number of clinical trials.
Professor Hugh Pennington, one of the UK’s foremost microbiologists, believes there is no justification for fast-tracking the vaccine.
He said, “The number of swine flu cases has dropped like a stone in recent weeks so I don’t see any real need to rush the vaccine through.
“We should be using the same kind of testing as for the seasonal flu jab.
Risks
“But we’ve had many years of experience in producing flu vaccines so if there are any risks they are likely to be very remote.
“I’m not in a priority group so won’t be eligible to have the jab but if I were I wouldn’t have any reservations.”
A spokesman for GlaxoSmithKline, one of two firms processing the swine flu vaccine, said, “The clinical trials are ongoing. But the decision as to who gets the vaccine and when is a matter for individual governments.”
A Department of Health spokeswoman said it had accepted liability for the safety of the vaccines as a contingency.
She added, “All governments signing up to an advance purchase agreement were expected to provide an indemnity for the vaccine and neither manufacturer would sign the contracts without it.
“The Government’s decision was based on the best procurement and legal advice.”
Link to this